Filling the need for trusted information on national health issues…

Intellectual Property and Trade

  • Your Selections:

Refine Results

date

Tags

Multilateral Banks Could Support LMICs’ Anti-Tobacco Policies

Noting a recent report in the New York Times about “Big Tobacco’s use of international trade and investment agreements to undermine anti-tobacco policies in low- and middle-income countries [LMICs],” Amanda Glassman, senior fellow and director of global health policy at the Center for Global Development (CGD), and Bill Savedoff, a…

Sharp Divide In Support Of South Africa’s Intellectual Property Reforms

Times of India: Access to medicines issue splits the world, developing vs developed “The recently concluded meeting of the World Health Organization’s executive board saw a sharp divide between developing and developed countries on the issue of South Africa’s reforms of its intellectual property laws to enable affordable access to…

South Africa, Drug Companies Spar Over Intellectual Property Laws

Reuters: South Africa slams Big Pharma in generic drugs row “South Africa on Friday slammed global drug firms over a covert campaign against its planned overhaul of intellectual property laws to favor cheaper generic drugs, accusing pharmaceutical companies of a ‘satanic’ plot to commit ‘genocide.’ … South Africa is in…

‘Science Speaks’ Blog Examines Proposal Against South Africa’s Draft IP Policy

The Center for Global Health Policy’s blog “Science Speaks” reports on a proposal prepared by U.S.-based PhRMA (Pharmaceutical Research and Manufacturers of America) and the South Africa-based IPASA (Innovative Pharmaceutical Association South Africa) in response to the South African government’s Draft National Policy on Intellectual Property (IP). The “proposal says…

TPP Will Not Hinder Access To Essential Medicines, U.S. Commerce Secretary Says

“A wide-ranging Asia-Pacific free trade agreement will not hinder access to affordable medication, the U.S. commerce secretary said on the sidelines of an Asia-Pacific Economic Cooperation (APEC) summit that concluded on October 8 in Bali, Indonesia,” IRIN reports. “But activists remain concerned after the closed-door trade talks concluded among” the…

Indian Health Activists Take Legal Action To Stop Patenting Of Gilead Hepatitis C Drug

“Indian health activists are seeking to prevent Gilead from patenting its new treatment for Hepatitis C in the country in a fresh battle over affordable access to medicine,” the Financial Times reports. “The Initiative for Medicines, Access & Knowledge in India said it had filed a ‘pre-grant’ application in Calcutta…

India Leads Efforts To Negotiate ‘Peace Clause’ In WTO Agriculture Agreement

“India and some other developing nations are trying to negotiate a cease-fire in a heated battle over food subsidies for the poor that is threatening to derail global trade talks, officials involved in the talks said,” the Wall Street Journal reports (Mukherji/Dalton, 11/24). “The G33 nations, a group of emerging…

Scientific American Examines Impact Of Government Shutdown On Health, Science Activities

Following approval of “a final deal to keep the [U.S.] government running until January 15, researchers across the nation say their work — some of it already compromised by the budget sequestration — will suffer lasting damage as a result of the 16-day shutdown,” Scientific American reports. “Health surveillance may…

G33 Group Pushes To Re-Open WTO Talks On Food Subsidy Rules

“The combined effects of the global economic slowdown and increasing climatic shocks are threatening food security in developing countries, prompting many to re-open World Trade Organization (WTO) discussions on limits to support for farmers,” IRIN reports. “A group of developing countries — known as G33 — is asking to exceed…

Reuters Examines Implications Of India’s Novartis Patent Ruling For Big Pharma

Reuters examines the implications of India’s Supreme Court ruling to overturn a patent on Novartis’s cancer treatment Glivec for the pharmaceutical industry in India and across the developing world. “Stung by a landmark patent defeat, Western drug makers will be wary about launching new products in India, but they cannot…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.